⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13668738 | 0.82 | — | — | |
| SCHEMBL2233762 | 0.82 | — | — | |
| SCHEMBL13337379 | 0.72 | AURKA (0.30) | — | |
| SCHEMBL4651282 | 0.68 | AURKA (0.30) | — | |
| SCHEMBL6236482 | 0.67 | TSHR (0.36) | — | |
| SCHEMBL6945846 | 0.67 | — | — | |
| Fimbrolide SCHEMBL1049932 | 0.63 | CDC25A (0.38) | — | |
| Fimbrolide SCHEMBL1049934 | 0.63 | CDC25A (0.38) | — | |
| SCHEMBL304472 | 0.63 | — | — | |
| SCHEMBL4651128 | 0.58 | TRPA1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160317771-A1 | PATIENT INTERFACE | KONINKLIJKE PHILIPS N.V. | 2016-11-03 | — | — | US | disclosed |
| US-8530680-B2 | System and method for controlling growth of microorganisms with brominated furanones | SYRACUSE UNIVERSITY (US) | 2013-09-10 | — | — | US | disclosed |
| US-8519166-B2 | System and method for controlling growth of microorganisms with brominated furanones | SYRACUSE UNIVERSITY (US) | 2013-08-27 | — | — | US | disclosed |
| US-20120264950-A1 | SYSTEM AND METHOD FOR CONTROLLING GROWTH OF MICROORGANISMS WITH BROMINATED FURANONES | SYRACUSE UNIVERSITY (US) | 2012-10-18 | — | — | US | disclosed |
| US-20100120905-A1 | SYSTEM AND METHOD FOR CONTROLLING GROWTH OF MICROORGANISMS WITH BROMINATED FURANONES | SYRACUSE UNIVERSITY (US) | 2010-05-13 | — | — | US | disclosed |